PHOTO
‘The center will play a major role in the development of medical services in Kuwait’ says Group representative
Kuwait City: Under the auspices of the Minister of Health, HE Sheikh Dr Basel Humoud Al Sabah, KIPCO – the Kuwait Projects Company (Holding) – inaugurated the Late Sheikha Salwa Sabah Al Ahmad Al Sabah Stem Cell and Umbilical Cord Center.
The center was built with a donation of KD 7 million made by Masharee Al Khair Charity Organization on behalf of KIPCO Group. This is the first center in the Gulf region to be dedicated to stem cell research and the storage of umbilical cords.
The facility, located adjacent to the Maternity Hospital in the Sabah Health Zone, is built over an area of 12,000 square meters and includes testing and research laboratories, blood and cord storage banks, research and medical libraries, as well as a lecture theater.
KIPCO hosted an inauguration ceremony, marking the handover of the building to the Ministry of Health. The event was attended by representatives of the Ministry of Health and senior executives of the KIPCO Group.
The Minister of Health, HE Sheikh Dr Basel Humoud Al Sabah, spoke about the importance of stem cell research and the groundbreaking discoveries made in this area that have a direct impact on the quality of people’s lives and the ability to cure previously incurable diseases. He thanked KIPCO and Masharee Al Khair Charity Organization for the donation, which not only reflects the private sector’s interest in the well-being of the community, but is also a symbol of its commitment to actively supporting the ‘New Kuwait’ Vision 2035.
Speaking at the ceremony, Mr Abdulaziz Al Jassar, KIPCO Group Representative, Board Member and Treasurer of Masharee Al Khair Charity Organization said:
“This center represents one of the forms of partnership between the public and private sectors, which have come together to push forth the development of this nation. We believe that the center, the first of its kind in the region, will play a major role in the development of medical services and science in Kuwait. Our goal, through building this center, is to contribute to healthier living. We look forward to the day when the storage of umbilical cords becomes the norm, and stem cells become the first option to overcome chronic diseases and other injuries that cannot be treated with traditional methods.”
He added:
“We chose to name the center after a woman who made social and charitable contributions for many years, away from the spotlight. We hope that this center will serve to remind us of the legacy of the late Sheikha Salwa Sabah Al Ahmad Al Sabah.”
Following their speeches, HE the Minister of Health and Mr Al Jassar unveiled the commemorative plaque, marking the official inauguration of the center. They were joined by Dr Reem Al Radwan, Director of the Department of Blood Transfusion Services at the Ministry of Health.
The event was concluded with a VIP tour of the facilities.
- Ends -
The KIPCO Group is one of the biggest holding companies in the Middle East and North Africa, with consolidated assets of US$ 33 billion as at 31 March 2019. The Group has significant ownership interests in over 60 companies operating across 24 countries. The group’s main business sectors are financial services, media, real estate and manufacturing. Through its core companies, subsidiaries and affiliates, KIPCO also has interests in the education and medical sectors.
The conversion rate used is US$1 to KD 0.30420
Further information:
Eman Al Awadhi
Group Communications Director
Corporate Communications Department
T: +965 2294 3416
M:+965 6033 6399
Eman.Alawadhi@kipco.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
